<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01067430</url>
  </required_header>
  <id_info>
    <org_study_id>IISP 35166</org_study_id>
    <nct_id>NCT01067430</nct_id>
  </id_info>
  <brief_title>Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA)</brief_title>
  <official_title>Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northumbria Healthcare NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northumbria Healthcare NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to explore the effect of Etoricoxib compared to Diclofenac on
      physical activity in RA subjects with early morning pain and stiffness.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">April 2011</completion_date>
  <primary_completion_date type="Anticipated">October 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To explore the effect of Etoricoxib compared to Diclofenac on physical activity in RA subjects with Early morning pain and stiffness.</measure>
    <time_frame>After 14 days of treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To explore the effect of Etoricoxib compared to Diclofenac on average daily pain scores, fatigue scores, and quality of life.</measure>
    <time_frame>After 14 days of treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Etoricoxib 90 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subject will take Etoricoxib 90 mg for 14 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diclofenac</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Film coated tablet 50 mgs given three times a day for 14 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Etoricoxib</intervention_name>
    <description>Film coated tablet, 90 mg taken once a day for 14 days</description>
    <arm_group_label>Etoricoxib 90 mg</arm_group_label>
    <other_name>Arcoxia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac</intervention_name>
    <description>Enteric coated tablet 50 mg given three times a day for 14 days</description>
    <arm_group_label>Diclofenac</arm_group_label>
    <other_name>Voltarol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female subjects aged 18 years and over.

          -  Subjects who are NSAID tolerant.

          -  Subjects with a clinical diagnosis of rheumatoid arthritis.

          -  Subjects who are willing to complete QOL questionnaires.

          -  Written informed consent

        Exclusion Criteria:

          -  Co-occurrence of other disabling conditions in addition to rheumatoid arthritis likely
             to warrant the persistent use of escape analgesia.

          -  Subjects who have received an intra-articular or muscular steroid injection within 3
             months of study entry or in whom such treatment is planned within the study period.

          -  Subjects scheduled for elective surgery of the disease site or any other elective
             major surgery which would fall within the study period.

          -  Severe respiratory impairment.

          -  Clinically significant hepatic or renal dysfunction, subjects whose LFTs and serum
             creatinine is outside normal recognized limits.

          -  Subjects with convulsive disorders, head injury, shock, reduced level of consciousness
             of uncertain origin, intracranial lesions or increased intracranial pressure.

          -  Subjects with a known allergy or hypersensitivity to NSAIDs.

          -  Subjects with unstable gastro-intestinal complications or disease.

          -  Subjects who currently abuse alcohol or drugs, or have a recent history of alcohol or
             drug abuse, or who in the Investigator's opinion, have previously demonstrated
             drug-seeking behaviour.

          -  Subjects who are currently participating in another clinical research study involving
             a new chemical entity or who have participated in a clinical study within the previous
             30 days.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>David J Walker, MD</last_name>
    <phone>01912231685</phone>
    <email>david.walker@nuth.nhs.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Northumbria Healthcare NHS Foundation Trust</name>
      <address>
        <city>North Shields</city>
        <state>Tyne and Wear</state>
        <zip>NE29 8NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>David J Walker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2010</study_first_submitted>
  <study_first_submitted_qc>February 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2010</study_first_posted>
  <last_update_submitted>February 10, 2010</last_update_submitted>
  <last_update_submitted_qc>February 10, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 11, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr David Walker</name_title>
    <organization>Newcastle Upon Tyne Hospitals NHS Foundation Trust</organization>
  </responsible_party>
  <keyword>Rheumatoid Arthritis</keyword>
  <keyword>Etoricoxib</keyword>
  <keyword>Diclofenac</keyword>
  <keyword>Pain</keyword>
  <keyword>Stiffness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Etoricoxib</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

